Gsα, protein kinase C, cathepsin D, growth factors, estrogen receptor- related protein, and p53 in prolactin cell adenomas and null cell adenomas of the pituitary

Endocrine Pathology

Volumn 9, Issue 2, 1998, Pages 135-148

  Wellhausen, Lars ^a   Saeger, Wolfgang ^a   Müller, Wolf ^a   Derwahl, Michael ^b   Harnacher, Christiane ^b   Lüdecke, Dieter K ^c  

^a Marienkrankenhaus ^*  (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Cathepsin D; EGF; Estrogen receptor related protein; Gs ; IGF 1; P53; Pituitary adenomas; Protein kinase C; TGF

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN; PROLACTIN; PROTEIN KINASE C; PROTEIN P53; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE;

EID: 0031825577     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02782606     Document Type: Article

References (49)

1. Liu M, Simon MI. Regulation by cAMP-dependent protein kinase of a G-protein-mediated phospholipase C. Nature 382: 83-87, 1996.
2. Couldwell WT, Law RE, Hinton DR, Gopalakrishna R, Yong VW, Weiss MH. Protein kinase C and growth regulation of pituitary adenomas. Acta Neurochir Suppl Wien 65:22-26, 1996.
3. Ishizuka T, Ito Y, Murayama M, Miura K, Nagao S, Nozawa Y. Hormone-induced redistribution of protein kinase C in human pituitary adenomas [letter]. Clin Chim Acta 170:351-353, 1987.
4. Adams EF, Brockmeier S, Friedmann E, Roth M, Buchtelder M, Fahlbusch R. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery 33:198-203, 1993.
5. Boothroyd CV, Grimmond SM, Cameron DP, Hayward NK. G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas. Biochem Biophys Res Commun 211:1063-1070, 1995.
6. Spada A, Vallar L. G-protein oncogenes in acromegaly. Horm Res 38:90-93, 1992.
7. Kute TE, Shao ZM, Sugg NK, Long RT, Russell GB, Case LD. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res 52:5198-5203, 1992.
8. Namer M, Ramaioli A, Fontana X, Etienne MC, Hery M, Jourlait A, et al. Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients. Breast Cancer Res Treat 19:85-93, 1991.
9. Pujol P, Maudelonde T, Daures JP, Rouanet P, Brouillet JP, Pujol H, et al. A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer 71:2006-2012, 1993.
10. Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, et al. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 2:1115-1118, 1989.
11. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL. Cathepsin D and prognosis in breast cancer [see comments]. N Engl J Med 322:297-302, 1990.
12. Granata G, Coradini D, Cappelletti V, Di Fronzo G. Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers [published erratum appears in Eur J Cancer 28(1):246, 1992]. Eur J Cancer 27:970-972, 1991.
13. Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, et al. Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol 12:467-474, 1994.
14. Alberti VN, Takita LC, de Mesquita MI, Percario S, Maciel RM. Immunohistochemical demonstration of insulin-like growth factor I (IGF-1) in normal and pathological human pituitary glands. Pathol Res Pract 187:541,542, 1991.
15. Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL. Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells. J Clin Endocrinol Metab 80:534-539, 1995.
16. Kontogeorgos G, Kovacs K, Scheithauer BW. Growth factors in the pituitary gland. Endocr Pathol 5:1-3, 1994.
17. LeRiche VK, Asa SL, Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 81:656-662, 1996.
18. Ren P, Scheithauer BW, Halper J. Immunohistological Localization of TGFalpha, EGF, IGF-1 and TGFbeta in the normal human pituitary gland. Endocr Pathol 5:40-48, 1994.
19. Finley EL, King JS, Ramsdell JS. Human pituitary somatotropes express transforming growth factor-alpha and its receptor. J Endocrinol 141:547-554, 1994.
20. Cohen KL, Nissley SP. The serum half-life of somatomedin: Evidence for growth hormone dependence. Acta Endocrinol 83:243-258, 1976.
21. Salmon WD, Daughaday WH. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836, 1957.
22. Ciocca DR, Luque EH. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res Treat 20:33-42, 1991.
23. Coffer AI, Lewis KM, Brockas AJ, King RJ. Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res 45:3686-3693, 1985.
24. Giani C, Campani D, De Negri F, Perpoli F, Capotorti E, Squartini F, et al. Value of ER-D5 immunocytochemical determination in routine tissue sections of human breast cancer. Int J Biol Markers 4:1-7, 1989.
25. Nardelli GB, Marson S, Crocco M, Coronella ML. A cytoplasmatic estrogen receptor related protein (ER-D5 Ag) in breast cancer. Eur J Gynaecol Oncol 10:141-143, 1989.
26. Navarro MA, Guardia M, Arranz B, Bonnin MR, Rosel P. ER-D5 antigen in breast cancer. J Cancer Res Clin Oncol 115:290,291, 1989.
27. Beck T, Pollow K, Heubner A. Monohlongle Antihörpes zem Nachweis des Oestrogenrezeptor-status eum Gewebe-Schmitt primärer Mammallareinome. Geburtshilfe Frauenheilkd 46:490-494, 1986.
28. van der Walt LA, Phillips JI, Afrika DJ. Oestrogen receptor assay by ER-D5 immunocytochemistry fails to correlate with ligand-binding assay in breast cancer. S Afr Med J 74:581-583, 1988.
29. Akslen LA, Varhaug JE. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21 ras protein, and proliferation indicators in relation to tumor recurrences and patient survival. Cancer 76: 1643-1654, 1995.
30. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, et al. P53 protein accumulates in Cushings adenomas and invasive nonfunctional adenomas [corrected and republished article originally printed in J Clin Endocrinol Metab 79(5): 1513-1516, 1994]. J Clin Endocrinol Metab 80:692-695, 1995.
31. Levy A, Lightman SL. The pathogenesis of pituitary adenomas. Clin Endocrinol Oxford 38:559-570, 1993.
32. Sumi T, Stefaneanu L, Kovacs K, Asa SL, Rindi G. Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol 4:95-99, 1993.
33. Herman V, Drazin NZ, Gonsky R, Melmed S. Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50-55, 1993.
34. Hamacher C, Studer H, Zbaeren J, Schatz H, Derwahl M. Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors [see comments]. J Clin Endocrinol Metab 80:1724-1732, 1995.
35. Derwahl M, Harnacher C, Russo D, Broecker M, Manole D, Schatz H, et al. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab 81:1898-1904, 1996.
36. Williamson EA, Daniels M, Foster S, Kelly WF, Kendall Taylor P, Harris PE. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumours. Clin Endocrinol Oxford 41:815-820, 1994.
37. Tordjman K, Stern N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjold M, et al. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 77:765-769, 1993.
38. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, et al. Two G protein oncogenes in human endocrine tumors. Science 249:655-659, 1990.
39. Bertherat J, Chanson P, Montminy M. The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol 9:777-783, 1995.
40. TodoT, Buchtelder M, Thierauf P, Fahlbusch R. Immunohistochemical expression of protein kinase C type III in human pituitary adenomas. Neurosurgery 32:635-642, 1993.
41. Alvaro V, Touraine P, Raisman Vozari R, Bai Grenier F, Birman P, Joubert D. Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int J Cancer 50:724-730, 1992.
42. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, et al. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 77:1125-1129, 1993.
43. Lübke D, Saeger W, Lüdecke DK. Proliferation markers and EGF in ACTH-secreting adenomas and carcinomas of the pituitary. Endocr Pathol 6:45-55, 1995.
44. Kobrin MS, Asa SL, Samsoondar J, Kudlow JE. Alpha-transforming growth factor in the bovine anterior pituitary gland: secretion by dispersed cells and immunohistochemical localization. Endocrinology 121:1412-1416, 1987.
45. Halper J, Parnell PG, Carter BJ, Ren P, Scheithauer BW. Presence of growth factors in human pituitary. Lab Invest 66: 639-645, 1992.
46. Kato M, Herz F, Kato S, Hirano A. Expression of stress-response (heat-shock) protein 27 in human brain tumors: an immunohistochemical study. Acta Neuropathol Berl 83:420-422, 1992.
47. Gandour-Edwards R, Kapadia SB, Janecka IP, Martinez AJ, Barnes L. Biologic markers of invasive pituitary adenomas involving the spheroid sinus. Mod Pathol 8:160-164, 1995.
48. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D. H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78:842-846, 1994.
49. Levy A, Hall L, Yeudall WA, Lightman SL. p53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol Oxford 41:809-814, 1994.